Holdings of Caligan Partners LP
23 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 80.9 % of the equity sleeve
Sector breakdown
- Unattributed 100.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 85.7 %
- FR 14.3 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 21 | 1.1B $ | 85.72 % |
| 2 | FR | 2 | 190.4M $ | 14.28 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Liquidia Corp | 8,118,892 | 306.4M $ | |
| 2 | Abivax SA | 1,461,924 | 162.8M $ | |
| 3 | Revolution Medicines Inc | 1,652,808 | 160.7M $ | |
| 4 | Vaxcyte Inc | 2,060,719 | 119.7M $ | |
| 5 | Mineralys Therapeutics Inc | 2,772,654 | 75.1M $ | |
| 6 | Exelixis Inc | 1,553,262 | 66.6M $ | |
| 7 | Tango Therapeutics Inc | 2,408,798 | 50.4M $ | |
| 8 | Tyra Biosciences Inc | 1,276,968 | 48.9M $ | |
| 9 | Spyre Therapeutics Inc | 878,127 | 44.3M $ | |
| 10 | ADMA Biologics Inc | 4,756,511 | 42.9M $ | |
| 11 | LB Pharmaceuticals Inc | 1,438,070 | 34.6M $ | |
| 12 | Vor BioPharma Inc | 1,925,066 | 34.3M $ | |
| 13 | SAB Biotherapeutics Inc | 7,967,207 | 30.5M $ | |
| 14 | Opus Genetics Inc | 6,075,028 | 27.6M $ | |
| 15 | Inventiva SACA | 4,974,906 | 27.6M $ | |
| 16 | MBX Biosciences Inc | 848,590 | 25.3M $ | |
| 17 | AVALO THERAPEUTICS INC | 1,635,023 | 24.4M $ | |
| 18 | Anika Therapeutics Inc | 1,435,130 | 20.8M $ | |
| 19 | Maze Therapeutics Inc | 614,962 | 18.4M $ | |
| 20 | Verrica Pharmaceuticals Inc | 923,910 | 4.9M $ | |
| 21 | SENSEI BIOTHERAPEUTICS INC | 126,002 | 4M $ | |
| 22 | Aura Biosciences Inc | 229,864 | 1.5M $ | |
| 23 | Xilio Therapeutics Inc | 112,128 | 943K $ |